
In January, follow-up results from the first six months of the British choroideremia gene therapy trial were published. At the Association for Vision Research and Ophthalmology meeting today, the team led by Dr. Robert…
Read More
The first human trial of a gene therapy for choroideremia has announced preliminary results on six people: two of these patients have experienced significant improvements in vision. The findings were published in…
Read More
1. Can you share with us what retinal eye disease you have and when you were diagnosed? The retinal disease I have is called Stargardt’s. It is when one has no central…
Read More
Can you share with us what retinal eye disease you have and when you were diagnosed? Retinitis Pigmentosa – 5 years old Did vision loss have any impact on your education choices?…
Read More
1. Can you share with us what retinal eye disease you have and when you were diagnosed? When I was 15, I was diagnosed with cataracts. I woke up one morning with…
Read More
An additional treatment option for people with wet age-related macular degeneration (AMD) will soon be available in Canada. Health Canada has just approved Eyelea, a drug made and marketed by Bayer Inc….
Read MoreJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.